12/1
08:30 am
vtgn
Vistagen Appoints Nick Tressler as Chief Financial Officer
High
Report
Vistagen Appoints Nick Tressler as Chief Financial Officer
11/26
08:30 am
vtgn
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting
Low
Report
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting
11/18
07:58 am
vtgn
Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026 [Seeking Alpha]
Medium
Report
Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026 [Seeking Alpha]
11/17
12:08 pm
vtgn
VistaGen Therapeutics (NASDAQ:VTGN) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
VistaGen Therapeutics (NASDAQ:VTGN) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
11/14
12:27 am
vtgn
Vistagen Therapeutics Inc (VTGN) Q2 2026 Earnings Call Highlights: Progress in Palisade 3 Trial ... [Yahoo! Finance]
Low
Report
Vistagen Therapeutics Inc (VTGN) Q2 2026 Earnings Call Highlights: Progress in Palisade 3 Trial ... [Yahoo! Finance]
11/13
07:07 pm
vtgn
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call Transcript [Seeking Alpha]
Neutral
Report
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call Transcript [Seeking Alpha]
11/12
08:37 am
vtgn
What To Expect From Vistagen Therapeutics Inc (VTGN) Q2 2026 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Vistagen Therapeutics Inc (VTGN) Q2 2026 Earnings [Yahoo! Finance]
11/10
08:30 am
vtgn
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
Low
Report
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
11/5
08:30 am
vtgn
Vistagen to Participate in Stifel Healthcare Conference 2025
Medium
Report
Vistagen to Participate in Stifel Healthcare Conference 2025
11/3
08:30 am
vtgn
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
Low
Report
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
10/29
08:30 am
vtgn
Vistagen Appoints Paul Edick to its Board of Directors
Low
Report
Vistagen Appoints Paul Edick to its Board of Directors
10/21
01:24 pm
vtgn
VistaGen Therapeutics (NASDAQ:VTGN) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
VistaGen Therapeutics (NASDAQ:VTGN) had its "outperform" rating reaffirmed by analysts at William Blair.
10/16
08:30 am
vtgn
Vistagen to Present at The Menopause Society 2025 Annual Meeting
Medium
Report
Vistagen to Present at The Menopause Society 2025 Annual Meeting
9/28
04:49 am
vtgn
Is Vistagen Therapeutics (NASDAQ:VTGN) In A Good Position To Invest In Growth? [Yahoo! Finance]
Low
Report
Is Vistagen Therapeutics (NASDAQ:VTGN) In A Good Position To Invest In Growth? [Yahoo! Finance]
9/26
05:55 pm
vtgn
Janus Henderson Just Took a 13.6% Stake in Vistagen. Should You Buy VTGN Stock Now? [Yahoo! Finance]
Low
Report
Janus Henderson Just Took a 13.6% Stake in Vistagen. Should You Buy VTGN Stock Now? [Yahoo! Finance]
9/9
08:30 am
vtgn
Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Medium
Report
Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit